author-photo

David R. Gandara

University of Texas MD Anderson Cancer Center

5

Papers

1247

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Official Title: CALGB-30506: A Randomized Phase III Trial of Adjuvant Therapy in Early Stage Non-Small-Cell Lung Cancer Evaluating the Potential Utility of a Genomic Prognostic Model to Identify Patients as Candidates for Adjuvant Chemotherapy Primary Endpoint: Overall survival (OS) at 5 years Sponsor: Cancer and Leukemia Group B; National Cancer Institute (NCI)

2009
Show All
- Source
- Cite
- Save
Citations (1)
Cooperative Group Research Efforts in Lung Cancer: Focus on Early-Stage Non-Small-Cell Lung Cancer comprehensive review

2008
Show All
- Source
- Cite
- Save
Citations (0)
Activity o f D ocetaxel i n P latinum-Treated N on-Small-Cell Lung C ancer: R esults o f a P hase I I M ulticenter T rial

2000
Show All
- Source
- Cite
- Save
Citations (0)
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

2000 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1246)
Randomized P hase I II T rial o f D ocetaxel V ersus Vinorelbine o r I fosfamide i n P atients W ith A dvanced N on- Small-Cell L ung C ancer P reviously T reated W ith P latinum- Containing C hemotherapy R egimens

2000
Show All
- Source
- Cite
- Save
Citations (0)